APA (7th ed.) Citation

M, E. R., M, G., MK, A., EA, S., W, D., Y, H., . . . I, W. (2017). Simeprevir plus sofosbuvir for eight or 12 weeks in treatment-naïve and treatment-experienced hepatitis C virus genotype 4 patients with or without cirrhosis. Journal of viral hepatitis, 24(2), 102. https://doi.org/10.1111/jvh.12625

Chicago Style (17th ed.) Citation

M, El Raziky, et al. "Simeprevir Plus Sofosbuvir for Eight or 12 Weeks in Treatment-naïve and Treatment-experienced Hepatitis C Virus Genotype 4 Patients with or Without Cirrhosis." Journal of Viral Hepatitis 24, no. 2 (2017): 102. https://doi.org/10.1111/jvh.12625.

MLA (9th ed.) Citation

M, El Raziky, et al. "Simeprevir Plus Sofosbuvir for Eight or 12 Weeks in Treatment-naïve and Treatment-experienced Hepatitis C Virus Genotype 4 Patients with or Without Cirrhosis." Journal of Viral Hepatitis, vol. 24, no. 2, 2017, p. 102, https://doi.org/10.1111/jvh.12625.